Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 1, 2014, Pages 615-625

  Kim, Tae Hyung ^a,b   Shin, Yu Jin ^a   Won, A Jin ^a   Lee, Byung Mu ^b   Choi, Wahn Soo ^c   Jung, Jee H ^a   Chung, Hae Young ^a   Kim, Hyung Sik ^b  

^a Pusan National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

Author keywords

Breast cancer; Doxorubicin; Drug resistant; Resveratrol

Indexed keywords

ABC TRANSPORTER; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN 1; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER RESISTANCE; CANCER SIZE; CELL STRAIN; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; DRUG TRANSPORT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MDR1 GENE; MOUSE; MRP1 GENE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

MUS MUSCULUS; RICE STRIPE VIRUS;

ABC TRANSPORTER; ATP-BINDING CASSETTE TRANSPORTER; BREAST CANCER; DIMETHYLSULFOXIDE; DMEM; DMSO; DOX; DOXORUBICIN; DOXORUBICIN-RESISTANT MCF-7; DRUG-RESISTANT; DULBECCO'S MODIFIED EAGLE MEDIUM; MCF-7/ADR; MDR; MRP; MULTI-DRUG RESISTANCE; MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN; P-GLYCOPROTEIN; P-GP; RESVERATROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RSV; RT-PCR; TERMINAL DEOXYNUCLOTIDYL TRANSFERASE DUTP NICK END LABELING; TUNEL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 84887140160     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.10.023     Document Type: Article

References (56)

1. L. Biganzoli, A. Minisini, M. Aapro, and A. Di Leo Chemotherapy for metastatic breast cancer Curr. Opin. Obstet. Gynecol. 16 2004 37 41 (Pubitemid 38241540)
2. C.E. Humber, J.F. Tierney, R.P. Symonds, M. Collingwood, J. Kirwan, C. Williams, and J.A. Green Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration Ann. Oncol. 18 2007 409 420 (Pubitemid 46359618)
3. A. Koceva-Chyla, M. Jedrzejczak, J. Skierski, K. Kania, and Z. Jozwiak Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation Apoptosis 10 2005 1497 1514 (Pubitemid 43117691)
4. F. Suzuki, K. Hashimoto, H. Kikuchi, H. Nishikawa, H. Matsumoto, J. Shimada, M. Kawase, K. Sunaga, T. Tsuda, K. Satoh, and H. Sakagami Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin Anticancer Res. 25 2005 887 893 (Pubitemid 40546859)
5. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol. Rev. 56 2004 185 229 (Pubitemid 38720829)
6. I.F. Faneyte, P.M. Kristel, M. Maliepaard, G.L. Scheffer, R.J. Scheper, J.H. Schellens, and M.J. van de Vijver Expression of the breast cancer resistance protein in breast cancer Clin. Cancer Res. 8 2002 1068 1074 (Pubitemid 35177357)
7. F.J. Esteva, V. Valero, L. Pusztai, L. Boehnke-Michaud, A.U. Buzdar, and G.N. Hortobagyi Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond Oncologist 6 2001 133 146 (Pubitemid 32323452)
8. J. Walker, C. Martin, and R. Callaghan Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy Eur. J. Cancer 40 2004 594 605 (Pubitemid 38220779)
9. C. Ruiz de Almodovar, C. Ruiz-Ruiz, C. Munoz-Pinedo, G. Robledo, and A. Lopez-Rivas The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels Oncogene 20 2001 7128 7133 (Pubitemid 33052207)
10. M.B. Gariboldi, R. Ravizza, L. Riganti, S. Meschini, A. Calcabrini, M. Marra, G. Arancia, E. Dolfini, and E. Monti Molecular determinants of intrinsic resistance to doxorubicin in human cancer cell lines Int. J. Oncol. 22 2003 1057 1064
11. Y. Pommier, O. Sordet, S. Antony, R.L. Hayward, and K.W. Kohn Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks Oncogene 23 2004 2934 2949 (Pubitemid 38638854)
12. M. Zilli, A. Grassadonia, N. Tinari, A. Di Giacobbe, S. Gildetti, J. Giampietro, C. Natoli, and S. Iacobelli Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer Biochim. Biophys. Acta 1795 2009 62 81
13. A.K. Tyagi, C. Agarwal, D.C. Chan, and R. Agarwal Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells Oncol. Rep. 11 2004 493 499
14. M. Fukui, N. Yamabe, and B.T. Zhu Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo Eur. J. Cancer 46 2010 1882 1891
15. Y. Kang, M.A. Park, S.W. Heo, S.Y. Park, K.W. Kang, P.H. Park, and J.A. Kim The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells Biochim. Biophys. Acta 1830 2013 2638 2648
16. Y. Schneider, F. Vincent, B. Duranton, L. Badolo, F. Gosse, C. Bergmann, N. Seiler, and F. Raul Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells Cancer Lett. 158 2000 85 91 (Pubitemid 30627485)
17. B.B. Aggarwal, and S. Shishodia Molecular targets of dietary agents for prevention and therapy of cancer Biochem. Pharmacol. 71 2006 1397 1421
18. F. Levi, C. Pasche, F. Lucchini, R. Ghidoni, M. Ferraroni, and C. La Vecchia Resveratrol and breast cancer risk Eur. J. Cancer Prev. 14 2005 139 142 (Pubitemid 40516975)
19. E.D. Danz, J. Skramsted, N. Henry, J.A. Bennett, and R.S. Keller Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway Free Radic. Biol. Med. 46 2009 1589 1597
20. W. Sun, W. Wang, J. Kim, P. Keng, S. Yang, H. Zhang, C. Liu, P. Okunieff, and L. Zhang Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment Adv. Exp. Med. Biol. 614 2008 179 186
21. E. Sexton, C. Van Themsche, K. LeBlanc, S. Parent, P. Lemoine, and E. Asselin Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells Mol. Cancer 5 2006 45
22. F. Casanova, J. Quarti, D.C. da Costa, C.A. Ramos, J.L. da Silva, and E. Fialho Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest J. Cell. Biochem. 113 2012 2586 2596
23. P. Kovacic, and R. Somanathan Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety Oxid. Med. Cell. Longev. 3 2010 86 100
24. G. Notas, A.P. Nifli, M. Kampa, J. Vercauteren, E. Kouroumalis, and E. Castanas Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation Biochim. Biophys. Acta 1760 2006 1657 1666 (Pubitemid 44667277)
25. T.T. Huang, H.C. Lin, C.C. Chen, C.C. Lu, C.F. Wei, T.S. Wu, F.G. Liu, and H.C. Lai Resveratrol induces apoptosis of human nasopharyngeal carcinoma cells via activation of multiple apoptotic pathways J. Cell. Physiol. 226 2011 720 728
26. J. Vanamala, L. Reddivari, S. Radhakrishnan, and C. Tarver Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways BMC Cancer 10 2010 238
27. M.H. Lee, B.Y. Choi, J.K. Kundu, Y.K. Shin, H.K. Na, and Y.J. Surh Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target Cancer Res. 69 2009 7449 7458
28. P. Boissy, T.L. Andersen, B.M. Abdallah, M. Kassem, T. Plesner, and J.M. Delaisse Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation Cancer Res. 65 2005 9943 9952 (Pubitemid 41541475)
29. H. Jiang, X. Shang, H. Wu, S.C. Gautam, S. Al-Holou, C. Li, J. Kuo, L. Zhang, and M. Chopp Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells J. Exp. Ther. Oncol. 8 2009 25 33
30. C. Zheng, L. Qiu, X. Yao, and K. Zhu Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: drug encapsulation and in vitro evaluation Int. J. Pharm. 373 2009 133 140
31. M. Prabaharan, J.J. Grailer, S. Pilla, D.A. Steeber, and S. Gong Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(l-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery Biomaterials 30 2009 3009 3019
32. W. Dean-Colomb, and F.J. Esteva Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer Semin. Oncol. 35 2008 S31 S38 (quiz S40)
33. A. Di Leo, D. Gancberg, D. Larsimont, M. Tanner, T. Jarvinen, G. Rouas, S. Dolci, J.Y. Leroy, M. Paesmans, J. Isola, and M.J. Piccart HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil Clin. Cancer Res. 8 2002 1107 1116 (Pubitemid 34517647)
34. T. L'Ecuyer, S. Sanjeev, R. Thomas, R. Novak, L. Das, W. Campbell, and R.V. Heide DNA damage is an early event in doxorubicin-induced cardiac myocyte death Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1273 H1280
35. A.K. Joe, H. Liu, M. Suzui, M.E. Vural, D. Xiao, and I.B. Weinstein Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin. Cancer Res. 8 2002 893 903 (Pubitemid 34742123)
36. N. Ahmad, V.M. Adhami, F. Afaq, D.K. Feyes, and H. Mukhtar Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells Clin. Cancer Res. 7 2001 1466 1473 (Pubitemid 32708704)
37. J. Dorrie, H. Gerauer, Y. Wachter, and S.J. Zunino Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells Cancer Res. 61 2001 4731 4739 (Pubitemid 32691883)
38. K.W. Scotto Transcriptional regulation of ABC drug transporters Oncogene 22 2003 7496 7511 (Pubitemid 37487172)
39. R.W. Johnstone, A.A. Ruefli, K.M. Tainton, and M.J. Smyth A role for P-glycoprotein in regulating cell death Leuk. Lymphoma 38 2000 1 11 (Pubitemid 30224318)
40. A. Zyad, J. Benard, T. Tursz, R. Clarke, and S. Chouaib Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression Cancer Res. 54 1994 825 831
41. H. Lage ABC-transporters: implications on drug resistance from microorganisms to human cancers Int. J. Antimicrob. Agents 22 2003 188 199 (Pubitemid 37103199)
42. F. Wang, X. Jiang, D.C. Yang, R.L. Elliott, and J.F. Head Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells Anticancer Res. 20 2000 799 808 (Pubitemid 30240636)
43. M.J. Ferreira, N. Gyemant, A.M. Madureira, M. Tanaka, K. Koos, R. Didziapetris, and J. Molnar The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line Anticancer Res. 25 2005 4173 4178 (Pubitemid 41665201)
44. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J. 22 2008 659 661 (Pubitemid 351348146)
45. M.D. Knutson, and C. Leeuwenburgh Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases Nutr. Rev. 66 2008 591 596
46. P. Guha, A. Dey, A. Chatterjee, S. Chattopadhyay, and S.K. Bandyopadhyay Pro-ulcer effects of resveratrol in mice with indomethacin-induced gastric ulcers are reversed by l-arginine Br. J. Pharmacol. 159 2010 726 734
47. A. Schlachterman, F. Valle, K.M. Wall, N.G. Azios, L. Castillo, L. Morell, A.V. Washington, L.A. Cubano, and S.F. Dharmawardhane Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model Transl. Oncol. 1 2008 19 27
48. F. Quan, C. Pan, Q. Ma, S. Zhang, and L. Yan Reversal effect of resveratrol on multidrug resistance in KBv200 cell line Biomed. Pharmacother. 62 2008 622 629
49. O. Wesolowska, J. Wisniewski, A. Bielawska-Pohl, M. Paprocka, N. Duarte, M.J. Ferreira, D. Dus, and K. Michalak Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells Anticancer Res. 30 2010 4587 4593
50. A.M. Al-Abd, A.M. Mahmoud, G.A. El-Sherbiny, M.A. El-Moselhy, S.M. Nofal, H.A. El-Latif, W.I. El-Eraky, and H.A. El-Shemy Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro Cell Prolif. 44 2011 591 601
51. L. Deng, Y.C. Lin-Lee, F.X. Claret, and M.T. Kuo 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway J. Biol. Chem. 276 2001 413 420 (Pubitemid 32050334)
52. M.T. Kuo, Z. Liu, Y. Wei, Y.C. Lin-Lee, S. Tatebe, G.B. Mills, and H. Unate Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling Oncogene 21 2002 1945 1954 (Pubitemid 34270883)
53. O. Fantappie, E. Masini, I. Sardi, L. Raimondi, D. Bani, M. Solazzo, A. Vannacci, and R. Mazzanti The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line Hepatology 35 2002 843 852 (Pubitemid 34258378)
54. J. Lamba, S. Strom, R. Venkataramanan, K.E. Thummel, Y.S. Lin, W. Liu, C. Cheng, V. Lamba, P.B. Watkins, and E. Schuetz MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype Clin. Pharmacol. Ther. 79 2006 325 338
55. S. Misra, S. Ghatak, and B.P. Toole Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2 J. Biol. Chem. 280 2005 20310 20315 (Pubitemid 40776728)
56. M. Zhan, D. Yu, J. Liu, R.I. Glazer, J. Hannay, and R.E. Pollock Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation J. Biol. Chem. 280 2005 4825 4833 (Pubitemid 40288655)